News | 21 July 2026
Bausch + Lomb launches EyeGility Inserter to streamline cataract lens delivery in US
The EyeGility system is designed to provide smooth, controlled lens delivery through a 2.4mm incision
The EyeGility system is designed to provide smooth, controlled lens delivery through a 2.4mm incision
The deal adds SPR’s FDA-cleared SPRINT PNS System to Medtronic’s neuroscience portfolio
Acquisition aims to take HST Medical's heritage wellness brands to international markets while strengthening product innovation
Revenue climbs 13.7% YoY to Rs. 1,129 million
New clinical-stage company to advance PRMT5 and SOS1 cancer programmes through global clinical development
Company tells NSE the imported menopause-care product contributes less than 1% of revenue and the disruption is not expected to materially affect financial performance
Company says voluntary dissolution of wholly owned subsidiary will have no material impact on business, with entity contributing nil revenue in FY26
Company says operations will continue for 15 days, corrective measures underway as it seeks revocation of closure order
Inspection at New York manufacturing facility concludes with a single Form 483 observation; company to submit corrective response
The acquisition gives GSK access to three promising lung cancer programmes
DST funding will help K.N. Biosciences commercialise IIT Guwahati's natural blue pigment technology, reducing import dependence and boosting India's bio-manufacturing ecosystem
The 12-week certification program is designed to provide students with industry-relevant knowledge through intensive modules across multiple scientific disciplines
The acquisition of Integrace further strengthens the firm's healthcare investment strategy and reflects growing investor confidence in India's branded formulations market
Senior scientists from Lupin, Mankind Pharma | Bharat Serums and Vaccines, Zydus Lifesciences, Panacea Biotec, Veeda Lifesciences, Shilpa Biologicals, Zumutor Biologics, InoRx and Mumbai Biocluster will discuss India's roadmap to becoming a global biosimilars and biologics hub
Zero-tariff access under the India-UK CETA is expected to boost generic medicine exports, strengthen supply chains and deepen investment and R&D partnerships
Company says active ingredient is clearly disclosed on all Aciloc packs and pledges full cooperation with authorities
Rs. 1,060-crore acquisition strengthens NATCO’s long-term growth strategy in the African pharmaceutical market
Exclusive marketing alliance brings gastro-protective pain management therapy for patients requiring long-term NSAID treatment
Subscribe To Our Newsletter & Stay Updated
_195_291.png){kind=logo}
